SCHEMBL6604411

SCHEMBL6604411

CCOC(=O)Cc1c[nH]c2cccc(N)c12

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 1/20 0.63
CHEK1 O14757 1/20 0.53
SMN1; SMN2 Q16637 3/20 0.48
CYP1A2 P05177 2/20 0.48
CYP3A4 P08684 2/20 0.48
CYP2C19 P33261 2/20 0.48
CYP2D6 P10635 1/20 0.48
CYP2C9 P11712 1/20 0.48
MAPT P10636 5/20 0.48
ALDH1A1 P00352 5/20 0.48
KMT2A Q03164 4/20 0.48
MEN1 O00255 3/20 0.48
GAA P10253 2/20 0.48
LMNA P02545 1/20 0.48
NPSR1 Q6W5P4 1/20 0.48
KDM4E B2RXH2 2/20 0.46
TDP1 Q9NUW8 3/20 0.46
POLB P06746 1/20 0.46
THRB P10828 1/20 0.46
DNMT1 P26358 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13083665 0.86 GAA (0.50) PKMSMN1; SMN2MAPTALDH1A1KMT2A
SCHEMBL5177500 0.85 PKM (0.68) PKMSMN1; SMN2CYP1A2CYP3A4CYP2C19
SCHEMBL8914837 0.84 PKM (0.63) PKMCHEK1SMN1; SMN2CYP1A2CYP3A4
SCHEMBL9936651 0.84 PKM (0.63) PKMCHEK1SMN1; SMN2CYP1A2CYP3A4
SCHEMBL261412 0.80 PKM (0.61) PKMSMN1; SMN2CYP1A2CYP3A4CYP2C19
SCHEMBL17704088 0.79 GPR84 (0.49) MAPTALDH1A1KMT2AMEN1GAA
SCHEMBL9662401 0.79 PKM (0.56) PKMSMN1; SMN2CYP1A2CYP3A4CYP2C19
SCHEMBL9437539 0.78 PKM (0.55) PKMCHEK1SMN1; SMN2CYP1A2CYP3A4
SCHEMBL361312 0.77 PKM (1.00) PKMSMN1; SMN2CYP1A2CYP3A4CYP2C19
SCHEMBL30419025 0.77 PKM (1.00) PKMSMN1; SMN2CYP1A2CYP3A4CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004101533-A1 1, 3, 4-BENZOTRIAZEPIN-2-ONE SALTS AND THEIR USE AS CCK RECEPTOR LIGANDS JANSSEN PHARMACEUTICA, N.V. (US) 2004-11-25 WO disclosed
EP-1443934-A1 BENZOTRIAZEPINES AS GASTRIN AND CHOLECYSTOKININ RECEPTOR LIGANDS JAMES BLACK FOUNDATION LIMITED (GB) 2004-08-11 EP disclosed
WO-2003041714-A1 BENZOTRIAZEPINES AS GASTRIN AND CHOLECYSTOKININ RECEPTOR LIGANDS JAMES BLACK FOUNDATION LIMITED (GB) 2003-05-22 WO disclosed